Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GE Medical

This article was originally published in The Gray Sheet

Executive Summary

Shareholders of Madison, Wisconsin-based Lunar Corp. will receive 0.322 shares of GE stock for each share of Lunar stock under terms of the firms' merger deal completed Aug. 8. Announced June 2, the agreement was valued at roughly $144 mil. A manufacturer of diagnostics for osteoporosis and metabolic bone disease as well as orthopedic surgery devices, Lunar will add $91 mil. in annual revenues to GE's $7 bil. Medical Systems business. GEMS hopes to accelerate Lunar's top-line growth above the single-digit pace of the overall bone densitometry market (1"The Gray Sheet" June 5, p. 13)

You may also be interested in...

GEMS Shooting At Moon In Women's Health Via Lunar Densitometry Buy

GE Medical Systems is looking to expand its women's health business by applying its worldwide marketing resources to increase the reach of Lunar Corporation's densitometry and orthopedic imaging brands.

'Purple Drank' Drug Cocktail Linked To France's Latest Reverse-Switch

Promethazine has been reverse-switched from OTC to prescription status in France, with rising abuse of the drug in the so-called Purple Drank cocktail one of the motivating factors for the move by the country's health ministry.

P&G Causes Friction With UK Cosmetics Firm Over Ad Claim

Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts